NCT02826291View on ClinicalTrials.gov

SLNM in Endometrial Cancer Combined With OSNA

CompletedOBSERVATIONAL
Enrollment

58

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

February 1, 2018

Conditions
Endometrial Cancer
Interventions
DEVICE

RD-100i, OSNA

quantitative reverse transcription polymerase chain reaction (qRT-PCR) cytokeratin-19 detection in specimen (sentinel lymph node)

Trial Locations (1)

30460

Faculty Hospital in Pilsen, Pilsen

All Listed Sponsors
collaborator

University Hospital Pilsen

OTHER

lead

Charles University, Czech Republic

OTHER

NCT02826291 - SLNM in Endometrial Cancer Combined With OSNA | Biotech Hunter | Biotech Hunter